

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.54829681 |
| 2 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.38215757 |
| 3 | histone H3-K36 demethylation (GO:0070544) | 4.20610344 |
| 4 | keratinization (GO:0031424) | 4.10159759 |
| 5 | regulation of histone H3-K27 methylation (GO:0061085) | 3.43831162 |
| 6 | cellular response to ethanol (GO:0071361) | 3.32334287 |
| 7 | regulation of Cdc42 GTPase activity (GO:0043088) | 3.17156971 |
| 8 | regulation of establishment of cell polarity (GO:2000114) | 3.16880805 |
| 9 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.13786389 |
| 10 | interferon-gamma secretion (GO:0072643) | 3.11914773 |
| 11 | ear development (GO:0043583) | 3.10846882 |
| 12 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.02767684 |
| 13 | histone H3-K4 trimethylation (GO:0080182) | 3.02638926 |
| 14 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.99634579 |
| 15 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.98271210 |
| 16 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.96285892 |
| 17 | positive regulation of humoral immune response (GO:0002922) | 2.92488415 |
| 18 | establishment of skin barrier (GO:0061436) | 2.88709474 |
| 19 | histone lysine demethylation (GO:0070076) | 2.87059673 |
| 20 | activation of Rac GTPase activity (GO:0032863) | 2.83922794 |
| 21 | regulation of water loss via skin (GO:0033561) | 2.79858739 |
| 22 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79671350 |
| 23 | negative regulation of osteoblast proliferation (GO:0033689) | 2.79391817 |
| 24 | striated muscle atrophy (GO:0014891) | 2.77655353 |
| 25 | semaphorin-plexin signaling pathway (GO:0071526) | 2.77444149 |
| 26 | histone demethylation (GO:0016577) | 2.75687016 |
| 27 | protein K11-linked deubiquitination (GO:0035871) | 2.68416096 |
| 28 | positive regulation of histone deacetylation (GO:0031065) | 2.67973368 |
| 29 | mannose metabolic process (GO:0006013) | 2.66717271 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 2.61904222 |
| 31 | negative regulation of interleukin-8 production (GO:0032717) | 2.61628138 |
| 32 | macroautophagy (GO:0016236) | 2.60890915 |
| 33 | histone H3-K4 methylation (GO:0051568) | 2.58492837 |
| 34 | positive regulation of Rac GTPase activity (GO:0032855) | 2.57859543 |
| 35 | endothelial cell chemotaxis (GO:0035767) | 2.55822859 |
| 36 | negative regulation of granulocyte differentiation (GO:0030853) | 2.54331593 |
| 37 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.51608981 |
| 38 | positive regulation of cholesterol efflux (GO:0010875) | 2.50963532 |
| 39 | positive regulation of protein kinase C signaling (GO:0090037) | 2.50382326 |
| 40 | skeletal muscle adaptation (GO:0043501) | 2.48766906 |
| 41 | histone H3-K9 demethylation (GO:0033169) | 2.48492652 |
| 42 | regulation of ruffle assembly (GO:1900027) | 2.47823349 |
| 43 | filopodium assembly (GO:0046847) | 2.47558002 |
| 44 | adherens junction assembly (GO:0034333) | 2.43746736 |
| 45 | snRNA transcription (GO:0009301) | 2.43525332 |
| 46 | cell-cell junction maintenance (GO:0045217) | 2.43503922 |
| 47 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.43197004 |
| 48 | positive regulation of epidermis development (GO:0045684) | 2.43029126 |
| 49 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.38944516 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 2.38789442 |
| 51 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.36193169 |
| 52 | positive regulation of glomerulus development (GO:0090193) | 2.36070055 |
| 53 | protein K48-linked deubiquitination (GO:0071108) | 2.35887435 |
| 54 | positive regulation of Rho GTPase activity (GO:0032321) | 2.35784775 |
| 55 | ovulation (GO:0030728) | 2.34347667 |
| 56 | regulation of ARF GTPase activity (GO:0032312) | 2.34292008 |
| 57 | positive regulation of p38MAPK cascade (GO:1900745) | 2.33876719 |
| 58 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.33527143 |
| 59 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.32272015 |
| 60 | protein dealkylation (GO:0008214) | 2.30803433 |
| 61 | protein demethylation (GO:0006482) | 2.30803433 |
| 62 | response to peptidoglycan (GO:0032494) | 2.29464388 |
| 63 | regulation of cellular amide metabolic process (GO:0034248) | 2.28683231 |
| 64 | negative regulation of cell size (GO:0045792) | 2.27811414 |
| 65 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.27712819 |
| 66 | negative regulation of fatty acid transport (GO:2000192) | 2.26397408 |
| 67 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.25944757 |
| 68 | receptor catabolic process (GO:0032801) | 2.25362249 |
| 69 | white fat cell differentiation (GO:0050872) | 2.25283106 |
| 70 | positive regulation of type 2 immune response (GO:0002830) | 2.25241356 |
| 71 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.25055017 |
| 72 | regulation of ARF protein signal transduction (GO:0032012) | 2.24467564 |
| 73 | cell-substrate adherens junction assembly (GO:0007045) | 2.23874910 |
| 74 | focal adhesion assembly (GO:0048041) | 2.23874910 |
| 75 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.23732157 |
| 76 | regulation of p38MAPK cascade (GO:1900744) | 2.23552371 |
| 77 | corticosteroid receptor signaling pathway (GO:0031958) | 2.22877057 |
| 78 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.22327961 |
| 79 | positive regulation of protein deacetylation (GO:0090312) | 2.22243386 |
| 80 | positive regulation of receptor recycling (GO:0001921) | 2.20398153 |
| 81 | regulation of histone deacetylation (GO:0031063) | 2.19424851 |
| 82 | response to muramyl dipeptide (GO:0032495) | 2.17484173 |
| 83 | peptidyl-lysine trimethylation (GO:0018023) | 2.17443633 |
| 84 | TOR signaling (GO:0031929) | 2.17191352 |
| 85 | establishment of protein localization to Golgi (GO:0072600) | 2.15642814 |
| 86 | histone lysine methylation (GO:0034968) | 2.15332095 |
| 87 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.15123175 |
| 88 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.13582977 |
| 89 | fibroblast migration (GO:0010761) | 2.13238656 |
| 90 | positive regulation of macroautophagy (GO:0016239) | 2.13137605 |
| 91 | positive regulation of osteoblast proliferation (GO:0033690) | 2.12691853 |
| 92 | germinal center formation (GO:0002467) | 2.12120612 |
| 93 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.11032156 |
| 94 | T-helper cell differentiation (GO:0042093) | 2.10896143 |
| 95 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.10896143 |
| 96 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.10494662 |
| 97 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.10084726 |
| 98 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.09774744 |
| 99 | angiogenesis involved in wound healing (GO:0060055) | 2.09602587 |
| 100 | macrophage activation (GO:0042116) | 2.08758061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.29074778 |
| 2 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.71611478 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.00116414 |
| 4 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.83568201 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.66033551 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.53587449 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51887482 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.45055463 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.41987434 |
| 10 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.39076118 |
| 11 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.37744214 |
| 12 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.31378724 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.26856421 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24569222 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.19042371 |
| 16 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.16170227 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.06137457 |
| 18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.95767426 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86832997 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81481588 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80907248 |
| 22 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.80432897 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75137632 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74217835 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73751420 |
| 26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.73748733 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72348322 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.70191751 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.69866338 |
| 30 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.66752893 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.64441521 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.63738852 |
| 33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.63305773 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62684271 |
| 35 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.58908998 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56044903 |
| 37 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.56023271 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52732467 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52551643 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51052879 |
| 41 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.48180030 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46584257 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45426122 |
| 44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.42175726 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41793848 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36407642 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36235222 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35106347 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32279819 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30712483 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29815982 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29775858 |
| 53 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.26151156 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26035953 |
| 55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24654994 |
| 56 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24083137 |
| 57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23391235 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.21913986 |
| 59 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21084433 |
| 60 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21084433 |
| 61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19772545 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19771106 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18026755 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17914441 |
| 65 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16266425 |
| 66 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12778374 |
| 67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11708943 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11057013 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.09049659 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08648038 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08340507 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07182163 |
| 73 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07005645 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06441991 |
| 75 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04899083 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04393847 |
| 77 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04287748 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02775982 |
| 79 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02227870 |
| 80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01786010 |
| 81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00915394 |
| 82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98778463 |
| 83 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98739758 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98429139 |
| 85 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97696009 |
| 86 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.96955112 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96717828 |
| 88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96473892 |
| 89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95413940 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95065298 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91321068 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90779102 |
| 93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89988911 |
| 94 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89160006 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88405558 |
| 96 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87875161 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87239041 |
| 98 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86919377 |
| 99 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86386366 |
| 100 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.85245448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004381_abnormal_hair_follicle | 3.81140094 |
| 2 | MP0005076_abnormal_cell_differentiation | 3.55901124 |
| 3 | MP0002796_impaired_skin_barrier | 3.02044100 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.90872989 |
| 5 | MP0000383_abnormal_hair_follicle | 2.76484755 |
| 6 | MP0005409_darkened_coat_color | 2.66027464 |
| 7 | MP0003183_abnormal_peptide_metabolism | 2.50944913 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.48439649 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.42312487 |
| 10 | MP0005451_abnormal_body_composition | 2.40765721 |
| 11 | MP0010678_abnormal_skin_adnexa | 2.36375313 |
| 12 | MP0003303_peritoneal_inflammation | 2.32327543 |
| 13 | MP0002009_preneoplasia | 2.29543735 |
| 14 | MP0005167_abnormal_blood-brain_barrier | 2.12974813 |
| 15 | MP0005310_abnormal_salivary_gland | 2.08120235 |
| 16 | MP0003453_abnormal_keratinocyte_physiol | 2.01564122 |
| 17 | MP0009278_abnormal_bone_marrow | 2.00116239 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 1.96972720 |
| 19 | MP0000371_diluted_coat_color | 1.93365643 |
| 20 | MP0000569_abnormal_digit_pigmentation | 1.91108091 |
| 21 | MP0004510_myositis | 1.90393460 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.89802432 |
| 23 | MP0003091_abnormal_cell_migration | 1.79951449 |
| 24 | MP0000767_abnormal_smooth_muscle | 1.74195343 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.72967370 |
| 26 | MP0004947_skin_inflammation | 1.69423685 |
| 27 | MP0001873_stomach_inflammation | 1.65849119 |
| 28 | MP0002254_reproductive_system_inflammat | 1.63961611 |
| 29 | MP0008260_abnormal_autophagy | 1.61102509 |
| 30 | MP0002998_abnormal_bone_remodeling | 1.55175807 |
| 31 | MP0005670_abnormal_white_adipose | 1.53837557 |
| 32 | MP0001849_ear_inflammation | 1.47588237 |
| 33 | MP0005501_abnormal_skin_physiology | 1.42042559 |
| 34 | MP0009115_abnormal_fat_cell | 1.40648638 |
| 35 | MP0002098_abnormal_vibrissa_morphology | 1.38729942 |
| 36 | MP0003436_decreased_susceptibility_to | 1.36011416 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.34011750 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.29081860 |
| 39 | MP0003878_abnormal_ear_physiology | 1.29081860 |
| 40 | MP0001790_abnormal_immune_system | 1.28116634 |
| 41 | MP0005387_immune_system_phenotype | 1.28116634 |
| 42 | MP0001800_abnormal_humoral_immune | 1.24640287 |
| 43 | MP0005375_adipose_tissue_phenotype | 1.22544986 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.21330200 |
| 45 | MP0002419_abnormal_innate_immunity | 1.20831677 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.20727317 |
| 47 | MP0002970_abnormal_white_adipose | 1.17923044 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.17048157 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.16857317 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.16857317 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.14975860 |
| 52 | MP0004233_abnormal_muscle_weight | 1.12287836 |
| 53 | MP0005647_abnormal_sex_gland | 1.11272347 |
| 54 | MP0006082_CNS_inflammation | 1.10189032 |
| 55 | MP0003279_aneurysm | 1.07771903 |
| 56 | MP0000003_abnormal_adipose_tissue | 1.07192054 |
| 57 | MP0000249_abnormal_blood_vessel | 1.07106192 |
| 58 | MP0005666_abnormal_adipose_tissue | 1.06764938 |
| 59 | MP0003045_fibrosis | 1.02058791 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.01574484 |
| 61 | MP0004883_abnormal_blood_vessel | 1.00200548 |
| 62 | MP0005000_abnormal_immune_tolerance | 0.99853123 |
| 63 | MP0005025_abnormal_response_to | 0.98315720 |
| 64 | MP0000015_abnormal_ear_pigmentation | 0.96069424 |
| 65 | MP0003828_pulmonary_edema | 0.95888242 |
| 66 | MP0002723_abnormal_immune_serum | 0.94948169 |
| 67 | MP0003300_gastrointestinal_ulcer | 0.94128487 |
| 68 | MP0009384_cardiac_valve_regurgitation | 0.94014561 |
| 69 | MP0003724_increased_susceptibility_to | 0.93818946 |
| 70 | MP0009840_abnormal_foam_cell | 0.91298732 |
| 71 | MP0005083_abnormal_biliary_tract | 0.90715705 |
| 72 | MP0002060_abnormal_skin_morphology | 0.89540096 |
| 73 | MP0002933_joint_inflammation | 0.89406717 |
| 74 | MP0008057_abnormal_DNA_replication | 0.89112422 |
| 75 | MP0005275_abnormal_skin_tensile | 0.88973193 |
| 76 | MP0000377_abnormal_hair_follicle | 0.88316842 |
| 77 | MP0002896_abnormal_bone_mineralization | 0.87936339 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 0.87418693 |
| 79 | MP0001533_abnormal_skeleton_physiology | 0.87170632 |
| 80 | MP0000733_abnormal_muscle_development | 0.86669936 |
| 81 | MP0002075_abnormal_coat/hair_pigmentati | 0.85661495 |
| 82 | MP0009931_abnormal_skin_appearance | 0.84373497 |
| 83 | MP0000427_abnormal_hair_cycle | 0.83902537 |
| 84 | MP0005248_abnormal_Harderian_gland | 0.82123473 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.79876390 |
| 86 | MP0000678_abnormal_parathyroid_gland | 0.79475241 |
| 87 | MP0005621_abnormal_cell_physiology | 0.77380185 |
| 88 | MP0010771_integument_phenotype | 0.75607021 |
| 89 | MP0001819_abnormal_immune_cell | 0.74942902 |
| 90 | MP0001851_eye_inflammation | 0.74715505 |
| 91 | MP0004043_abnormal_pH_regulation | 0.73884069 |
| 92 | MP0002420_abnormal_adaptive_immunity | 0.73695203 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.73302939 |
| 94 | MP0002971_abnormal_brown_adipose | 0.72448392 |
| 95 | MP0005334_abnormal_fat_pad | 0.72079316 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.71707142 |
| 97 | MP0005023_abnormal_wound_healing | 0.71335367 |
| 98 | MP0003948_abnormal_gas_homeostasis | 0.68974768 |
| 99 | MP0005464_abnormal_platelet_physiology | 0.67754600 |
| 100 | MP0005448_abnormal_energy_balance | 0.67712977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | J-shaped sella turcica (HP:0002680) | 4.32491599 |
| 2 | Deformed sella turcica (HP:0002681) | 3.73796431 |
| 3 | Broad face (HP:0000283) | 3.60904692 |
| 4 | Abnormality of nail color (HP:0100643) | 3.51913651 |
| 5 | Sparse lateral eyebrow (HP:0005338) | 3.45115517 |
| 6 | Abnormality of the sella turcica (HP:0002679) | 3.22939003 |
| 7 | Cerebral aneurysm (HP:0004944) | 3.22256807 |
| 8 | Genetic anticipation (HP:0003743) | 3.16899633 |
| 9 | Abnormality of the fingertips (HP:0001211) | 3.15916587 |
| 10 | Hyperacusis (HP:0010780) | 3.00669840 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 2.99000769 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.83131697 |
| 13 | Lip pit (HP:0100267) | 2.78889758 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.72185973 |
| 15 | Mucopolysacchariduria (HP:0008155) | 2.72185973 |
| 16 | Colitis (HP:0002583) | 2.70766899 |
| 17 | Obstructive sleep apnea (HP:0002870) | 2.68647659 |
| 18 | Cervical subluxation (HP:0003308) | 2.68220049 |
| 19 | Absent frontal sinuses (HP:0002688) | 2.66362887 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65517592 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65517592 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65517592 |
| 23 | Parakeratosis (HP:0001036) | 2.53426828 |
| 24 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.46853424 |
| 25 | Narrow palate (HP:0000189) | 2.44104647 |
| 26 | Loss of speech (HP:0002371) | 2.43467500 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.40632456 |
| 28 | Thin bony cortex (HP:0002753) | 2.39183955 |
| 29 | Increased IgE level (HP:0003212) | 2.38111384 |
| 30 | Glomerulonephritis (HP:0000099) | 2.28349623 |
| 31 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.27214999 |
| 32 | Flat acetabular roof (HP:0003180) | 2.26887478 |
| 33 | Long eyelashes (HP:0000527) | 2.26769211 |
| 34 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26491467 |
| 35 | Germ cell neoplasia (HP:0100728) | 2.18824896 |
| 36 | Abnormality of the epiphyses of the hand (HP:0005924) | 2.13036297 |
| 37 | Thick nail (HP:0001805) | 2.09086314 |
| 38 | Syringomyelia (HP:0003396) | 2.08690953 |
| 39 | Spinal cord lesions (HP:0100561) | 2.08690953 |
| 40 | Lymphangioma (HP:0100764) | 2.08549864 |
| 41 | Dysmetric saccades (HP:0000641) | 2.07643138 |
| 42 | Optic neuritis (HP:0100653) | 2.06268737 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.06268737 |
| 44 | Esophageal varix (HP:0002040) | 2.05602352 |
| 45 | Laryngomalacia (HP:0001601) | 2.05490781 |
| 46 | Abnormality of the thoracic spine (HP:0100711) | 2.00751901 |
| 47 | Urethral obstruction (HP:0000796) | 2.00012332 |
| 48 | Septate vagina (HP:0001153) | 1.97365913 |
| 49 | Nuclear cataract (HP:0100018) | 1.96399775 |
| 50 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.94669117 |
| 51 | Orchitis (HP:0100796) | 1.92793085 |
| 52 | Persistence of primary teeth (HP:0006335) | 1.91625347 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 1.88861203 |
| 54 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.88002400 |
| 55 | Concave nail (HP:0001598) | 1.87376387 |
| 56 | Macroorchidism (HP:0000053) | 1.85768578 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 1.85264590 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 1.85196112 |
| 59 | Hemorrhage of the eye (HP:0011885) | 1.85002798 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 1.82588356 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.82588356 |
| 62 | Deep philtrum (HP:0002002) | 1.82397590 |
| 63 | Neuronal loss in central nervous system (HP:0002529) | 1.81392726 |
| 64 | Abnormality of the radial head (HP:0003995) | 1.81122739 |
| 65 | Hypopigmentation of the fundus (HP:0007894) | 1.80930097 |
| 66 | Cone-rod dystrophy (HP:0000548) | 1.80251909 |
| 67 | Spondylolisthesis (HP:0003302) | 1.78841749 |
| 68 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.77369070 |
| 69 | Ocular albinism (HP:0001107) | 1.73717259 |
| 70 | Recurrent bacterial skin infections (HP:0005406) | 1.72690864 |
| 71 | Long toe (HP:0010511) | 1.72489018 |
| 72 | Thick eyebrow (HP:0000574) | 1.71922755 |
| 73 | Hyperkalemia (HP:0002153) | 1.71482896 |
| 74 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.70466147 |
| 75 | Distal upper limb amyotrophy (HP:0007149) | 1.70213569 |
| 76 | Upper limb amyotrophy (HP:0009129) | 1.70213569 |
| 77 | Renovascular hypertension (HP:0100817) | 1.69403406 |
| 78 | Neonatal hypoglycemia (HP:0001998) | 1.68123673 |
| 79 | Dislocated radial head (HP:0003083) | 1.68099518 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.67491191 |
| 81 | Ectropion (HP:0000656) | 1.67256868 |
| 82 | Asymmetry of the thorax (HP:0001555) | 1.65795542 |
| 83 | Thoracic kyphosis (HP:0002942) | 1.65382794 |
| 84 | Mediastinal lymphadenopathy (HP:0100721) | 1.64466336 |
| 85 | Abnormality of the columella (HP:0009929) | 1.63085584 |
| 86 | Smooth philtrum (HP:0000319) | 1.62503724 |
| 87 | Prominent nose (HP:0000448) | 1.61770289 |
| 88 | Natal tooth (HP:0000695) | 1.61348040 |
| 89 | Precocious puberty (HP:0000826) | 1.60434251 |
| 90 | Vitreoretinal degeneration (HP:0000655) | 1.59487762 |
| 91 | Abnormality of glycolipid metabolism (HP:0010969) | 1.59202552 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.59202552 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.59202552 |
| 94 | Hematochezia (HP:0002573) | 1.58247655 |
| 95 | Systemic lupus erythematosus (HP:0002725) | 1.57949209 |
| 96 | Advanced eruption of teeth (HP:0006288) | 1.56314508 |
| 97 | Neoplasm of the heart (HP:0100544) | 1.56011063 |
| 98 | Curly hair (HP:0002212) | 1.55677106 |
| 99 | Morphological abnormality of the middle ear (HP:0008609) | 1.55055034 |
| 100 | Slow saccadic eye movements (HP:0000514) | 1.54391423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.90368573 |
| 2 | SIK1 | 3.75185717 |
| 3 | PKN2 | 3.31368567 |
| 4 | EPHA2 | 3.07670240 |
| 5 | BLK | 2.80919215 |
| 6 | CDK12 | 2.79068056 |
| 7 | AKT3 | 2.57040100 |
| 8 | CHUK | 2.00634131 |
| 9 | ICK | 1.85484502 |
| 10 | RIPK1 | 1.80939727 |
| 11 | CDC42BPA | 1.70935913 |
| 12 | CSF1R | 1.69747833 |
| 13 | ERN1 | 1.67880155 |
| 14 | TNK2 | 1.53641177 |
| 15 | MARK2 | 1.51370828 |
| 16 | MTOR | 1.48491219 |
| 17 | MAPK15 | 1.44224547 |
| 18 | IRAK3 | 1.44082298 |
| 19 | IKBKE | 1.39563594 |
| 20 | MUSK | 1.38326258 |
| 21 | MAPKAPK3 | 1.32184860 |
| 22 | RIPK4 | 1.30809637 |
| 23 | FRK | 1.28941163 |
| 24 | TGFBR2 | 1.28019205 |
| 25 | SGK2 | 1.27914171 |
| 26 | EEF2K | 1.27908013 |
| 27 | NEK6 | 1.23911584 |
| 28 | MAP4K1 | 1.20232462 |
| 29 | CAMK1D | 1.20078743 |
| 30 | SGK3 | 1.19491153 |
| 31 | CAMK1G | 1.16030840 |
| 32 | TBK1 | 1.07519040 |
| 33 | MAP3K7 | 1.07044458 |
| 34 | FGFR4 | 1.01870960 |
| 35 | RPS6KA2 | 1.01499143 |
| 36 | BMX | 0.97535707 |
| 37 | IKBKB | 0.95808618 |
| 38 | SIK2 | 0.92821238 |
| 39 | PDPK1 | 0.92336718 |
| 40 | JAK1 | 0.91114380 |
| 41 | PDGFRB | 0.87527459 |
| 42 | PIK3CA | 0.87262368 |
| 43 | MAP3K6 | 0.86514492 |
| 44 | ERBB2 | 0.86420823 |
| 45 | RET | 0.86370664 |
| 46 | PDK1 | 0.86203101 |
| 47 | MAP3K3 | 0.85830292 |
| 48 | PRKD2 | 0.83758582 |
| 49 | PIM2 | 0.81298815 |
| 50 | MAPK7 | 0.81241156 |
| 51 | RPS6KL1 | 0.79994491 |
| 52 | RPS6KC1 | 0.79994491 |
| 53 | PTK6 | 0.79461108 |
| 54 | MAP3K13 | 0.79025041 |
| 55 | BTK | 0.79024094 |
| 56 | FGR | 0.77779950 |
| 57 | PRPF4B | 0.74374471 |
| 58 | SGK223 | 0.73032381 |
| 59 | SGK494 | 0.73032381 |
| 60 | RPS6KA6 | 0.72821911 |
| 61 | HIPK2 | 0.72201704 |
| 62 | TYK2 | 0.70238476 |
| 63 | BMPR2 | 0.70237637 |
| 64 | BRD4 | 0.68641317 |
| 65 | MAP2K3 | 0.68183609 |
| 66 | MAP3K14 | 0.67812743 |
| 67 | SMG1 | 0.66994063 |
| 68 | PDGFRA | 0.66756332 |
| 69 | GRK6 | 0.66104076 |
| 70 | CSK | 0.64499090 |
| 71 | CDK6 | 0.64199001 |
| 72 | IRAK4 | 0.60088408 |
| 73 | HCK | 0.58043865 |
| 74 | TYRO3 | 0.57803741 |
| 75 | FER | 0.57748792 |
| 76 | TAOK1 | 0.56798568 |
| 77 | MAPK8 | 0.56701760 |
| 78 | PTK2 | 0.56101377 |
| 79 | TTN | 0.56039185 |
| 80 | TRPM7 | 0.55900919 |
| 81 | MAP3K10 | 0.53339022 |
| 82 | TXK | 0.53238621 |
| 83 | MATK | 0.52002577 |
| 84 | PRKAA2 | 0.50690566 |
| 85 | MELK | 0.49714962 |
| 86 | MAP3K1 | 0.48719276 |
| 87 | MAPK11 | 0.48543189 |
| 88 | JAK3 | 0.48064976 |
| 89 | DYRK1B | 0.47265188 |
| 90 | RPS6KB2 | 0.46347906 |
| 91 | MAPK10 | 0.45130777 |
| 92 | MAP2K4 | 0.44417403 |
| 93 | PRKAA1 | 0.43430174 |
| 94 | CAMK4 | 0.43068884 |
| 95 | IRAK2 | 0.43015535 |
| 96 | RPS6KA1 | 0.41842710 |
| 97 | MAPK1 | 0.41732571 |
| 98 | PRKD1 | 0.41462436 |
| 99 | IRAK1 | 0.41419047 |
| 100 | ITK | 0.41126239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.82315494 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.23284688 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80391777 |
| 4 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.70239689 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.69475026 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59998177 |
| 7 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59331624 |
| 8 | Lysine degradation_Homo sapiens_hsa00310 | 1.55288424 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54627439 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46184169 |
| 11 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.42954458 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38466219 |
| 13 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.37668718 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37628287 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36045598 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.35530325 |
| 17 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.35221238 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32969867 |
| 19 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28057849 |
| 20 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.27669778 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25459713 |
| 22 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.24639429 |
| 23 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.22919604 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22809978 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22669072 |
| 26 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.21806918 |
| 27 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.20224867 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18990437 |
| 29 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16539659 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15848207 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.14284767 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 1.13474356 |
| 33 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.12717489 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12548972 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10677462 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10590554 |
| 37 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.09934486 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.09711408 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08652375 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07926459 |
| 41 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.07480326 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06933989 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.06857587 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06647891 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03329533 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02204423 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.01659331 |
| 48 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.99875103 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 0.98518603 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98331698 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94965979 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94779406 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 0.91739416 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91188706 |
| 55 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89602611 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.89594448 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.87755443 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 0.86263184 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.85174775 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84757910 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.83481973 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82673885 |
| 63 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.82426460 |
| 64 | Malaria_Homo sapiens_hsa05144 | 0.82286627 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82016543 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.81060735 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80456014 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.80052504 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77755113 |
| 70 | Focal adhesion_Homo sapiens_hsa04510 | 0.75796309 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75012246 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.73705079 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73511255 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71936407 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71453578 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70583289 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69972937 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68139594 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67961189 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66727411 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64682195 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.63658651 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.62966161 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62743437 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60361493 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59548147 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.59527418 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55804701 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54870886 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54602703 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54592718 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50463856 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50402297 |
| 94 | Axon guidance_Homo sapiens_hsa04360 | 0.50399660 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49850368 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48335246 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48308727 |
| 98 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47798096 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46595320 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45595483 |

